Mechanisms of red blood cell transfusion-related immunomodulation

N/ACitations
Citations of this article
131Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Red blood cell (RBC) transfusion is common in critically ill, postsurgical, and posttrauma patients in whom both systemic inflammation and immune suppression are associated with adverse outcomes. RBC products contain a multitude of immunomodulatory mediators that interact with and alter immune cell function. These interactions can lead to both proinflammatory and immunosuppressive effects. Defining clinical outcomes related to immunomodulatory effects of RBCs in transfused patients remains a challenge, likely due to complex interactions between individual blood product characteristics and patient-specific risk factors. Unpacking these complexities requires an in-depth understanding of the mechanisms of immunomodulatory effects of RBC products. In this review, we outline and classify potential mediators of RBC transfusion-related immunomodulation and provide suggestions for future research directions.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Remy, K. E., Hall, M. W., Cholette, J., Juffermans, N. P., Nicol, K., Doctor, A., … Muszynski, J. A. (2018, March 1). Mechanisms of red blood cell transfusion-related immunomodulation. Transfusion. Blackwell Publishing Inc. https://doi.org/10.1111/trf.14488

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 39

64%

Researcher 16

26%

Professor / Associate Prof. 5

8%

Lecturer / Post doc 1

2%

Readers' Discipline

Tooltip

Medicine and Dentistry 45

65%

Nursing and Health Professions 10

14%

Biochemistry, Genetics and Molecular Bi... 9

13%

Immunology and Microbiology 5

7%

Save time finding and organizing research with Mendeley

Sign up for free